EC Gynaecology

Case Report Volume 13 Issue 10 - 2024

Benckiser's Hemorrhage Case Report

Abdeladim Ayadine*, Abdelhamid Benlghazi, Echarfaoui Othmane, Houyame Zennati, Moulay Mehdi Elhassani and Jaouad Kouach

Department of Gynecology-Obstetrics, Mohammed V Military University Hospital, Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, Morocco

*Corresponding Author: Abdeladim Ayadine, Department of Gynecology-Obstetrics, Mohammed V Military University Hospital, Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, Morocco.
Received: September 12, 2024; Published: September 24, 2024



Benckiser’s hemorrhage is a rare yet serious cause of vaginal bleeding in the third trimester of pregnancy. It is associated with 75 to 100% rate of perinatal mortality.

The best way to manage these situations is by antenatal diagnosis via ultrasounds, then a prophylactic c-section could be performed avoiding cataclysmic consequences.

We are sharing with the readers a case of Benckiser’s hemorrhage of a patient with no antenatal diagnosis of vasa previa, presented to obstetric emergency department with vaginal bleeding at 34th week of gestation.

 Keywords: Benckiser’s Hemorrhage; Vasa Previa; Abnormal Placentation; Third Trimester Bleeding; Obstetric Emergency

  1. Bronsteen R., et al. “Vasa previa: clinical presentations, outcomes, and implications for management”. Obstetrics and Gynecology2 (2013): 352-357.
  2. Rebarber A., et al. “Natural history of vasa previa across gestation using a screening protocol”. Journal of Ultrasound in Medicine 1 (2014): 141-147.
  3. Robert M and Silver M. “Abnormal placentation placenta previa, vasa previa, and placenta accreta”. Obstetrics and Gynecology3 (2015): 654-668.
  4. G Aissi., et al. “Vasa previa: of the diagnosis to neonatal prognosis”. Journal de Gynecologie, Obstetrique et Biologie de la Reproduction6 (2013): 591-595.
  5. Ruiter L., et al. “Incidence of and risk indicators for vasa praevia: a systematic review”. BJOG: An International Journal of Obstetrics and Gynaecology 8 (2016): 1278-1287.
  6. Andrew D Hull., et al. “Creasy and Resnik's maternal-fetal medicine, placenta previa and accreta, vasa previa, subchorionic hemorrhage, and abruptio placentae”.
  7. Oyelese Y SJ. “Placenta previa, placenta accreta, and vasa previa”. Obstetrics and Gynecology4 (2006): 927-941.
  8. Rebarber A., et al. “Natural history of vasa previa across gestation using a screening protocol”. Journal of Ultrasound in Medicine 1 (2014): 141-147.
  9. Baulies S., et al. “Prenatal ultrasound diagnosis of vasa praevia and analysis of risk factors”. Prenatal Diagnosis 7 (2007): 595-599.
  10. Ruiter L., et al. “Incidence of and risk indicators for vasa praevia: a systematic review”. BJOG: An International Journal of Obstetrics and Gynaecology 8 (2016): 1278-1287.
  11. Sutera M., et al. Journal of Perinatal Medicine 49 (2021): 915.
  12. Venu Jain., et al. “Guideline No. 439: Diagnosis and management of vasa previa”. Journal of Obstetrics and Gynaecology Canada 7 (2023): 506-518.
  13. Sinkey RG., et al. “Diagnosis and management of vasa previa”. American Journal of Obstetrics and Gynecology 213 (2015): 615-619.
  14. Oyelese Y., et al. “Vasa previa: the impact of prenatal diagnosis on outcomes”. Obstetrics and Gynecology5 (2004): 937-942.

Abdeladim Ayadine., et al. "Benckiser's Hemorrhage Case Report". EC Gynaecology 13.10 (2024): 01-04.